CELL AND GENE THERAPY INSIGHTS

A practical guide to fit-for-purpose analytical development in an emerging cell therapy landscape

A practical guide to fit-for-purpose analytical development in an emerging cell therapy landscape

Damian Marshall, Jie Wei, Florian Durst
18 June 2025
Expert Roundtable
Producing MSC-derived cell therapies: workflows, technologies, and case studies

Producing MSC-derived cell therapies: workflows, technologies, and case studies

I Malaspina, S Mei, T Ting et al
28 March 2025
Expert Roundtable
Why peer review matters: insights from the scientific community

Why peer review matters: insights from the scientific community

A Goyal, A Cockroft, P Theocharous et al
28 February 2025
Expert Roundtable
Early-stage analytical development strategies for cell therapy

Early-stage analytical development strategies for cell therapy

Ramon Mendoza, Kyle Carter, Seth Peterson
16 January 2025
Expert Roundtable
Preparing for success in gene therapy purification

Preparing for success in gene therapy purification

X Fu, A Sharma, A D Tustian et al
05 December 2024
Expert Roundtable
Preparing for success in gene therapy analytical development

Preparing for success in gene therapy analytical development

Yan Zhi, Jing Li, Andres Castillo
02 December 2024
Expert Roundtable
iPSC-based therapy dilemmas explored: overcoming hurdles for future success

iPSC-based therapy dilemmas explored: overcoming hurdles for future success

M Carpenter, L Munsie, K Raineri et al
03 September 2024
Expert Roundtable
Unveiling the critical pathways in AAV potency evaluation and future trends in gene therapy

Unveiling the critical pathways in AAV potency evaluation and future trends in gene therapy

David Rangel, Guangping Gao, Nathalie Clement
09 August 2024
Expert Roundtable
Smooth cell therapy analytical assay translation from analytical development to QC

Smooth cell therapy analytical assay translation from analytical development to QC

H H Adams, I Shestopalov, K Yeung et al
28 February 2024
Expert Roundtable
Fast-tracking gene therapy breakthroughs: discussing the critical role of rapid testing

Fast-tracking gene therapy breakthroughs: discussing the critical role of rapid testing

R Legmann, G Thakur, S Levy et al
05 January 2024
Expert Roundtable
Biological & operational considerations for iPSC-derived cell production

Biological & operational considerations for iPSC-derived cell production

A Mogen, A Fernandez-Perez, J Wang et al
20 December 2023
Expert Roundtable
Current issues & future trends in cryopreservation for advanced therapies

Current issues & future trends in cryopreservation for advanced therapies

Jason Acker, Allison Hubel, Sean Werner
20 December 2023
Expert Roundtable
Cell culture in immune cell therapies: do more with less

Cell culture in immune cell therapies: do more with less

Anastasiya Smith, Josh Ludwig, David Hermanson
08 June 2023
Expert Roundtable
Navigating evolving regulatory CMC guidance in the AAV gene therapy field

Navigating evolving regulatory CMC guidance in the AAV gene therapy field

M Brewer, A Cockroft, C Fuentes et al
15 May 2023
Expert Roundtable
Accelerating cancer therapies development: the importance of platform, process, and partnership

Accelerating cancer therapies development: the importance of platform, process, and partnership

William Swaney, John (Yoshi) Shyu, Nikhil Tyagi
22 April 2023
Expert Roundtable
Driving the expansion of mRNA into the therapeutic sphere

Driving the expansion of mRNA into the therapeutic sphere

Alejandro Becerra, Andreas Kuhn, Metin Kurtoglu
10 April 2023
Expert Roundtable
AAV process development & scale-up

AAV process development & scale-up

Catherine Cancian, Karen Doucette, Reinout Hesselink
07 March 2023
Expert Roundtable
Diagnostic & therapeutic uses for extracellular vesicles: insights into a rapidly evolving field

Diagnostic & therapeutic uses for extracellular vesicles: insights into a rapidly evolving field

S Wild, J Correia, A de Fougerolles et al
30 November 2022
Expert Roundtable
Autologous versus allogeneic: the future of manufacturing and standardization in cell therapies

Autologous versus allogeneic: the future of manufacturing and standardization in cell therapies

Rupa Pike, Delara Motlagh, Patrick Hanley
05 October 2022
Expert Roundtable
Vaccine development in the COVID-19 era: regulatory challenges & innovation

Vaccine development in the COVID-19 era: regulatory challenges & innovation

P Marks, M Cavaleri, C Vinals et al
12 May 2022
Expert Roundtable
Strategies for scaling up and out in gene therapy manufacturing: addressing AAV’s growing pains

Strategies for scaling up and out in gene therapy manufacturing: addressing AAV’s growing pains

Christopher Reardon, Phillip Vermilion, John Yoshi Shyu
22 March 2022
Expert Roundtable